Valid for Submission
D89.833 is a billable diagnosis code used to specify a medical diagnosis of cytokine release syndrome, grade 3. The code D89.833 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The code D89.833 describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D89.833 are found in the index:
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|814||RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC||16||1.8907|
|815||RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC||16||0.9925|
|816||RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC||16||0.6609|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
D89833 replaces the following previously assigned ICD-10 code(s):